Abstract
A novel 4-aminocyclopentapyrrolidine series of N-type Ca(2+) channel blockers have been discovered. Enantioselective synthesis of the 4-aminocyclopentapyrrolidines was enabled using N-tert-butyl sulfinamide chemistry. SAR studies demonstrate selectivity over L-type Ca(2+) channels. N-type Ca(2+) channel blockade was confirmed using electrophysiological recording techniques. Compound 25 is an N-type Ca(2+) channel blocker that produces antinociception in inflammatory and nociceptive pain models without exhibiting cardiovascular or motor liabilities.
Copyright © 2012 Elsevier Ltd. All rights reserved.
MeSH terms
-
Acetamides / chemical synthesis*
-
Acetamides / pharmacology
-
Acetamides / therapeutic use
-
Analgesics / chemical synthesis*
-
Analgesics / pharmacology
-
Analgesics / therapeutic use
-
Animals
-
Behavior, Animal / drug effects
-
Calcium Channel Blockers / chemical synthesis*
-
Calcium Channel Blockers / pharmacology
-
Calcium Channel Blockers / therapeutic use
-
Calcium Channels, N-Type / chemistry*
-
Calcium Channels, N-Type / metabolism
-
Disease Models, Animal
-
Male
-
Pain / drug therapy
-
Pyrrolidines / chemical synthesis*
-
Pyrrolidines / chemistry*
-
Pyrrolidines / pharmacology
-
Pyrrolidines / therapeutic use
-
Rats
-
Rats, Sprague-Dawley
-
Structure-Activity Relationship
Substances
-
2,2-dicyclohexyl-N-(2-(3-(trifluoromethyl)benzyl)octahydrocyclopenta(c)pyrrol-4-yl)acetamide
-
Acetamides
-
Analgesics
-
Calcium Channel Blockers
-
Calcium Channels, N-Type
-
Pyrrolidines
-
pyrrolidine